Here’s what you’ll learn when you read this story: Treating Alzheimer’s requires a multi-faceted approach that can target various mechanisms behind this pernicious neurodegenerative disease. In a new ...

Loading the Elevenlabs Text to Speech AudioNative Player... There is a certain kind of critic for whom the obvious is much too monotonous. Call them contrarians, call them defiers of conventional ...

New research suggests that taking 3,000 steps or more a day can lower the risk of cognitive decline, even in people who are high risk. More steps had even greater benefits. Researchers discovered that ...

During National Alzheimer’s Disease Awareness Month, we recognize the immense toll this devastating illness takes on millions of Americans and the families, friends, and caregivers who love and care ...

A few years ago, my dad was diagnosed with Alzheimer’s disease, just like his older brother and his mum before him. Slowly, his personality began to ebb away. Now, at the age of 75, his cognitive ...

The Carpe Diem String Quartet will celebrate its 20th anniversary with the 2025-26 “Seize the Music” series. Performances will take place at various Columbus-area venues from October 2025 through May ...

Andrew “SpaceDrakeCF” Dice, one of the founders of Carpe Fulgur, died. Co-founder Robin Light-Williams announced the publisher and localization company head’s passing on social media. Carpe Fulgur ...

This article is part of “Innovations In: Alzheimer's Disease” an editorially independent special report that was produced with financial support from Eisai. Alzheimer’s disease has proved to be a ...

Scientists at the University of Bath have developed a simple three-minute brainwave test called Fastball EEG that can detect memory problems years before Alzheimer’s is typically diagnosed. Unlike ...

A recent study from Harvard Medical School asks whether the element lithium might be a key factor in whether someone develops Alzheimer’s disease. Led by Dr. Bruce Yankner, professor of genetics and ...

Lithium deficiency in the brain could be a cause of Alzheimer's disease—and a new potential target for treatment. Ten years in the making, this is the finding of researchers at Harvard Medical School ...